We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.94B
AUM Growth
+$184M
Cap. Flow
-$79.5M
Cap. Flow %
-2.7%
Top 10 Hldgs %
42.7%
Holding
135
New
34
Increased
27
Reduced
33
Closed
29

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$53.9M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
BIIB icon
Biogen
BIIB
+$40.8M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$36.6M
5
ULTA icon
Ulta Beauty
ULTA
+$35M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$57.2M
2
MRK icon
Merck
MRK
+$43.5M
3
WSM icon
Williams-Sonoma
WSM
+$40.2M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$38.7M
5
LOW icon
Lowe's Companies
LOW
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Consumer Staples 11.86%
3 Consumer Discretionary 11.13%
4 Technology 1.98%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$411M 13.99%
11,000
– –
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$294M 10%
15,000
-1,000
-6% -$175K
AVTX icon
3
Avalo Therapeutics
AVTX
$976M
$79.6M 2.71%
10,463
+41
+0.4% +$285K
SUPN icon
4
Supernus Pharmaceuticals
SUPN
$2.68B
$78.5M 2.67%
3,120,000
-80,000
-3% -$1.72M
VNDA icon
5
Vanda Pharmaceuticals
VNDA
$312M
$70.9M 2.41%
5,399,277
-50,723
-0.9% -$611K
LNTH icon
6
Lantheus
LNTH
$6.82B
$70.1M 2.39%
5,200,000
+364,000
+8% +$4.77M
BMY icon
7
Bristol-Myers Squibb
BMY
$127B
$64.3M 2.19%
1,036,000
+36,000
+4% +$2.21M
REGN icon
8
Regeneron Pharmaceuticals
REGN
$68.8B
$63.8M 2.17%
132,000
+48,000
+57% +$25.9M
BIIB icon
9
Biogen
BIIB
$29.9B
$63.2M 2.15%
258,000
+158,000
+158% +$40.8M
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$59.7M 2.03%
272,000
+104,000
+62% +$22.5M
INCY icon
11
Incyte
INCY
$23.5B
$59M 2.01%
678,000
+42,000
+7% +$3.63M
ENTA icon
12
Enanta Pharmaceuticals
ENTA
$372M
$57.1M 1.94%
1,356,000
+832,000
+159% +$36.6M
WMT icon
13
Walmart Inc
WMT
$871B
$53.4M 1.82%
+1,110,675
New +$53.9M
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$49M 1.67%
572,000
-328,000
-36% -$27.8M
FIVE icon
15
Five Below
FIVE
$11.2B
$46.9M 1.6%
268,185
+143,985
+116% +$21.3M
ALKS icon
16
Alkermes
ALKS
$8.82B
$44.2M 1.5%
2,216,000
+92,000
+4% +$1.68M
PTCT icon
17
PTC Therapeutics
PTCT
$6.37B
$43.7M 1.49%
716,000
-8,000
-1% -$472K
ENR icon
18
Energizer
ENR
$1.44B
$41.3M 1.4%
978,000
-700,000
-42% -$29.6M
ORLY icon
19
O'Reilly Automotive
ORLY
$72.4B
$41M 1.39%
+1,358,745
New +$41M
ULTA icon
20
Ulta Beauty
ULTA
$20.4B
$39.7M 1.35%
+138,304
New +$35M
CENTA icon
21
Central Garden & Pet Co Class A
CENTA
$2.41B
$38.7M 1.31%
1,330,000
+115,000
+9% +$3.37M
BLUE
22
DELISTED
bluebird bio
BLUE
$38M 1.29%
67,782
+6,022
+10% +$3.82M
CPB icon
23
Campbell Soup
CPB
$6.51B
$37.1M 1.26%
768,000
-148,000
-16% -$7.15M
MDGL icon
24
Madrigal Pharmaceuticals
MDGL
$12.6B
$35.1M 1.19%
316,000
+38,000
+14% +$4.64M
UNH icon
25
UnitedHealth
UNH
$382B
$35.1M 1.19%
100,000
-50,000
-33% -$16.8M
1
2 3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Armistice Capital held 135 positions worth $2.94B, up 6.7% from $2.76B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Armistice Capital's Q4 2020 filing shows 34 new, 27 increased, 33 reduced and 29 closed positions. Its largest new stake was Walmart Inc: 1,110,675 shares worth $53.4M. The largest sale was Alexion Pharmaceuticals, an estimated $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2020 buy was Walmart Inc: 1,110,675 shares worth $53.4M.
  • Armistice Capital added most to Biogen in Q4 2020, an estimated $40.8M increase.
  • Armistice Capital's biggest Q4 2020 reduction was Energizer, cutting an estimated $29.6M.
  • Armistice Capital fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $57.2M.
  • Armistice Capital's ten largest holdings make up 43% of its $2.94B portfolio in Q4 2020.
  • Armistice Capital opened 34 new positions and closed 29 in Q4 2020.
  • Armistice Capital's portfolio value rose 6.7% quarter-over-quarter to $2.94B.

Based on Armistice Capital's 13F filing for Q4 2020, filed 16 Feb 2021.